Alliance Advocates for Access, ICER Misses the Mark, and Jim Scott Takes a Closer Look at Vision Loss
Several Alliance staff attended the Alzheimer's Impact Movement rally across from the
White House on March 20.
Alliance Advocates for Equitable Access to Alzheimer’s Treatment
The Alliance continues to work toward dismantling the barrier to access an FDA-approved treatment proven to slow the pace of cognitive decline in patients in the early stages of Alzheimer’s disease. Read about our most recent efforts to draw attention to this issue in The Wall Street Journal and STAT News, and radio interviews like this one.
For more on this topic, follow #StopRationingCare on social media.
Despite Stated Concern, ICER Doesn’t Plan to Make Meaningful Changes to Address Equity
The Institute for Clinical and Economic Review's (ICER) recent report on health equity lacks any meaningful plan to change their value assessment methodology to help incentivize the development of therapeutics that advance equity.
Podcast: Kick QALY to the Curb A Conversation with Terry Wilcox of Patients Rising
This month, we welcome back Co-Founder and CEO of Patients Rising, Terry Wilcox to break down the impact of the quality adjusted life year on patients whose quality of life relies on
access to crucial treatments.